Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

QIAGEN-sponsored Award Granted for Pioneering Work on Viral Infections and the Cell Biology of Protein Folding

Published: Friday, April 09, 2010
Last Updated: Friday, April 09, 2010
Bookmark and Share
The Finnish scientist Ari Helenius has received the Otto-Warburg-Medal of the German Society for Biochemistry and Molecular Biology.

Today the Finnish scientist Ari Helenius has received the Otto-Warburg-Medal of the German Society for Biochemistry and Molecular Biology (GBM). The medal is considered the highest German honor for biochemists and molecular biologists.

Helenius explored how viruses change the programming of their host cells to their own benefit. In doing so he also discovered basic principles of biological “quality control” for the folding and assembly of protein molecules. QIAGEN, leading provider of sample and assay technologies, exclusively sponsors the Otto-Warburg-Medal with a grant of 25 000 Euros. Helenius received the award today in Mosbach, Germany.

Viruses proliferate by entering living cells and replicating there – generally to the disadvantage of the infected cell. Professor Ari Helenius explored the molecular processes of how influenza viruses manipulate their host cells, in particular by studying the synthesis and folding of Hemagglutinin. This protein molecule is being built into the virus membrane.

Helenius discovered that the attacked cell not only produces more Hemagglutinin and transports it to the membrane surface – it also checks it with a quality control system, which is actually in place for normal host cell proteins. Only functional proteins that are folded accurately and have the right structure will be processed by this biochemical “sorting -machine”.

Special enzymes recognize misfolded proteins and then a sugar molecule is added as an attachment to them. Proteins having this marker cannot leave the endoplasmic reticulum, the location where they have been assembled. This testing of newly synthesized proteins is of vital importance: a faulty molecular quality control can be the cause for different diseases like cystic fibrosis and diabetes. The concepts developed by Ari Helenius are now textbook knowledge.

“Ari Helenius strongly influenced the cell biological research over decades and developed innovative experimental approaches,” says Prof. Nikolaus Pfanner, president of the GBM. „The far ranging concepts he developed based on these discoveries are commonly accepted today. A better understanding of viral infections and cellular quality control established by his work could disclose new therapeutic options in medicine in the near future.”

“We are excited to see the Otto-Warburg-Medal awarded to Ari Helenius, a pioneer of science whose findings have brought substantial advance in several disciplines,” says Dr. Thomas Schweins, Vice President Marketing and Strategy at QIAGEN. „As a provider of a multitude of solutions for sample preparation and analysis of DNA, RNA and proteins we are delighted that we can support Ari Helenius with this year’s award and in his future research.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

QIAGEN Partners with Exosome Diagnostics
Molecular testing of biofluids promises unprecedented access to gene mutations, gene expression signatures and expression levels without costly, invasive tissue biopsies.
Wednesday, July 24, 2013
Qiagen Subsidiary SABiosciences Expands RT2 Profiler PCR Arrays
Now more than 100 arrays for various disease areas available
Monday, July 05, 2010
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!